On the other hand, a larger gauge needle, such as 30, may cause less discomfort during injection due to its finer size

Important Safety Information Do not use AOD-9604 if you: Have a known hypersensitivity to growth hormone fragments or any component of the formulation Have active malignancy (cancer that is currently being treated or monitored) Are pregnant or breastfeeding (insufficient safety data) Have a history of severe allergic reactions to peptide therapies Common side effects (typically mild and transient): Headache, mild gastrointestinal disturbances (flatulence, mild diarrhea at higher doses), upper respiratory tract symptoms, injection site reactions (redness, mild discomfort) Seek medical attention if you experience: Signs of allergic reaction (hives, difficulty breathing, swelling of face or throat), persistent gastrointestinal symptoms, unexplained significant changes in energy, mood, or physical symptoms Clinical Safety Data Safety studies involving approximately 900 participants across six randomized controlled trials documented that AOD-9604 displayed a very good safety and tolerability profile indistinguishable from placebo across most parameters

Our commitment at Real Peptides extends beyond simply providing high-purity research-grade peptides
A simple blood test can provide answers and determine if a B12 deficiency is the cause
COMBINATION THERAPIES Various fixed-dose combination antiobesity drugs are in different phases of clinical development
Pregnant or breastfeeding women, people with copper metabolism disorders like Wilsons disease, and anyone with active skin infections should speak with a doctor before starting